In vitro activation of anti-CD3 and anti-CD28 antibodies allows IFN-γ to generate CD4 + CD25+ regulatory T cells (iTregs) from CD4 + CD25− T cells in GBS patients (24). The gene discussed is IFNG; the disease is Guillain-Barre syndrome.